TP53 gene plays a major role in the process of malignant transformation and
tumour progression so that abnormalities such as point mutation or allelic
loss of this gene are a common finding in different tumour types. Most of
the mutations identified cover a conserved region of the gene, spanning fro
m exon 4 to exon 9. The present report describes a novel polymorphism, 12 n
ucleotides downstream the splicing junction of exon/intron 9 identified in
a cohort of 103 Italian healthy blood donors. The polymorphism results in t
he creation of a new restriction site for Ava I. (C) 1999 Academic Press.